Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Abbott in the Drug Discovery & Development Pharma 50

Abbott (Established Pharmaceutical Products)

Rank: 41

2021 Rank: 38

Abbott Park, Illinois, United States
www.abbott.com

2021 Revenues ($USD) : $4,718,000,000
2021 R&D spend : na
2021 Number of Employees : na
Fiscal Year End : 12/31/2021
Leader : CEO Robert B. Ford

After it spun off AbbVie in 2013, Abbott continued to focus on selling off-patent medicines. The established pharmaceuticals division has a significant presence in India, Vietnam, Pakistan, Latin America and South America. In all, Abbott’s Established Pharmaceutical Products serves more than 100 countries. In 2021, the pharmaceutical division generated $4.718 billion in revenue, close to 11% of the firm’s total. —BB

Abbott Laboratories

[Abbott Labs and downtown Chicago. Image courtesy of Wikipedia.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE